Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$365,941
+$9,270 QoQ
Shares Held
2,335
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,028
of 1,603 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Shoker Investment Counsel, Inc. holds $20,628,640 across 8 Drug Manufacturers - General names. NVS ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
21,930 | $5,518,465 | |
| 2 | JNJ |
Johnson & Johnson
|
18,845 | $4,786,064 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,948 | $3,848,318 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
20,774 | $2,624,587 | |
| 5 | PFE |
Pfizer Inc
|
99,923 | $2,406,145 | |
| 6 | LLY |
ELI LILLY & Co
|
668 | $801,219 | |
| 7 | NVS |
Novartis AG
This page
|
2,335 | $365,941 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,823 | $277,901 |
All Filings in NVS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $365,941 | 2,335 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $356,671 | 2,335 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $321,926 | 2,335 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $299,440 | 2,335 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $282,558 | 2,335 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $260,305 | 2,335 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $227,218 | 2,335 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $268,571 | 2,335 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $248,584 | 2,335 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $234,570 | 2,425 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $244,852 | 2,425 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $244,973 | 2,405 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $242,688 | 2,405 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $221,260 | 2,405 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $218,181 | 2,405 | Shares | Sole | 2023-02-10 | |
| 2022-06-30 | $203,294 | 2,405 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $211,038 | 2,405 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $210,365 | 2,405 | Shares | Sole | 2022-02-07 | |
| 2021-06-30 | $227,461 | 2,493 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $272,168 | 3,184 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $308,691 | 3,269 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $291,229 | 3,349 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $292,501 | 3,349 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $276,125 | 3,349 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||